Inotuzumab Ozogamycin (I0), a CD22 Monoclonal Antibody Conjugated to Calecheamicin, Is Active in Refractory-Relapse Acute Lymphocytic Leukemia (R-R ALL)
暂无分享，去创建一个
H. Kantarjian | J. Cortes | F. Ravandi | E. Jabbour | S. O'brien | A. Advani | J. Jorgensen | Sa A. Wang | L. Fayad | R. Champlin | S. Faderl | P. Kebriaei | M. Ohanian | M. Rytting | M. Rios | S. York | M. Kwari | R. Tarnai | D. Thomas